p.80 抽出テキスト

treated by transcatheter edge-to-edge repair: the EuroSMR risk score. Eur Heart J 2024;45:922–36. https://doi.org/10.1093/eurheartj/ehad871 83. Adamo M, Rubbio AP, Zaccone G, Pighi M, Massussi M, Tomasoni D, et al. Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score. EuroIntervention 2023;18:1408–17. https://doi.org/ 10.4244/EIJ-D-22-00992 84. Dreyfus J, Audureau E, Bohbot Y, Coisne A, Lavie-Badie Y, Bouchery M, et al. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J 2022;43:654–62. https://doi.org/10.1093/eurheartj/ ehab679 85. Dreyfus J, Bohbot Y, Coisne A, Lavie-Badie Y, Flagiello M, Bazire B, et al. Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery. Heart 2023;109:951–8. https://doi.org/10.1136/heartjnl-2022-322167 86. Lantelme P, Aubry M, Peng JC, Riche B, Souteyrand G, Jaafar P, et al. Comorbidities may offset expected improved survival after transcatheter aortic valve replacement. Eur Heart J Open 2022;2:oeac029. https://doi.org/10.1093/ehjopen/oeac029 87. Piankova P, Afilalo J. Prevalence and prognostic implications of frailty in transcatheter aortic valve replacement. Cardiol Clin 2020;38:75–87. https://doi.org/10.1016/j.ccl.2019.09.011 88. Kim DH, Afilalo J, Shi SM, Popma JJ, Khabbaz KR, Laham RJ, et al. Evaluation of changes in functional status in the year after aortic valve replacement. JAMA Intern Med 2019; 179:383–91. https://doi.org/10.1001/jamainternmed.2018.6738 89. Scotti A, Coisne A, Granada JF, Driggin E, Madhavan MV, Zhou Z, et al. Impact of malnutrition in patients with heart failure and secondary mitral regurgitation: the COAPT Trial. J Am Coll Cardiol 2023;82:128–38. https://doi.org/10.1016/j.jacc.2023.04.047 89a. Pagnesi M, Adamo M, Stolz L, Pancaldi E, Kresoja KP, von Stein J, et al. Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair. Eur J Heart Fail 2025. https://doi.org/10.1002/ejhf.3623. Epub ahead of print. PMID: 39980251. 90. Sündermann SH, Bäck C, Bischoff-Ferrari HA, Dehbi HM, Szekely A, Völler H, et al. Preinterventional frailty assessment in patients scheduled for cardiac surgery or transcatheter aortic valve implantation: a consensus statement of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Preventive Cardiology (EAPC) of the European Society of Cardiology (ESC). Eur J Cardiothorac Surg 2023;64:ezad181. https://doi.org/10.1093/ejcts/ezad181 91. Richter D, Guasti L, Walker D, Lambrinou E, Lionis C, Abreu A, et al. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur J Prev Cardiol 2022;29:216–27. https://doi.org/10. 1093/eurjpc/zwaa167 92. Kundi H, Popma JJ, Reynolds MR, Strom JB, Pinto DS, Valsdottir LR, et al. Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. Eur Heart J 2019;40:2231–9. https://doi.org/10.1093/eurheartj/ehz187 93. Brusco NK, Atkinson V, Woods J, Myles PS, Hodge A, Jones C, et al. Implementing PROMS for elective surgery patients: feasibility, response rate, degree of recovery and patient acceptability. J Patient Rep Outcomes 2022;6:73. https://doi.org/10.1186/ s41687-022-00483-6 94. Arnold SV, Spertus JA, Lei Y, Allen KB, Chhatriwalla AK, Leon MB, et al. Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis. Circ Heart Fail 2013;6:61–7. https://doi.org/10.1161/circheartfailure.112.970053 95. Arnold SV, Spertus JA, Gosch K, Dunlay SM, Olds DM, Jones PG, et al. Validation of the Kansas City Cardiomyopathy Questionnaire in patients with tricuspid regurgitation. JAMA Cardiol 2025;10:117–25 https://doi.org/10.1001/jamacardio.2024.4266 96. Clavel MA, Tribouilloy C, Vanoverschelde JL, Pizarro R, Suri RM, Szymanski C, et al. Association of B-type natriuretic peptide with survival in patients with degenerative mitral regurgitation. J Am Coll Cardiol 2016;68:1297–307. https://doi.org/10.1016/j. jacc.2016.06.047 97. Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, et al. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol 2014;63:2016–25. https://doi.org/10.1016/j.jacc.2014.02.581 98. Zhang B, Xu H, Zhang H, Liu Q, Ye Y, Hao J, et al. Prognostic value of N-terminal pro– B-type natriuretic peptide in elderly patients with valvular heart disease. J Am Coll Cardiol 2020;75:1659–72. https://doi.org/10.1016/j.jacc.2020.02.031 99. Lindman BR, Breyley JG, Schilling JD, Vatterott AM, Zajarias A, Maniar HS, et al. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. Heart 2015;101:1382–8. https://doi.org/10. 1136/heartjnl-2015-307742 100. Lindman BR, Clavel MA, Abu-Alhayja’a R, Cote N, Dagenais F, Novak E, et al. Multimarker approach to identify patients with higher mortality and rehospitalization rate after surgical aortic valve replacement for aortic stenosis. JACC Cardiovasc Interv 2018;11:2172–81. https://doi.org/10.1016/j.jcin.2018.07.039 101. Henri C, Piérard LA, Lancellotti P, Mongeon F-P, Pibarot P, Basmadjian AJ. Exercise testing and stress imaging in valvular heart disease. Can J Cardiol 2014;30:1012–26. https://doi.org/10.1016/j.cjca.2014.03.013 102. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005;26:1309–13. https://doi.org/10.1093/eurheartj/ehi250 103. Redfors B, Pibarot P, Gillam LD, Burkhoff D, Bax JJ, Lindman BR, et al. Stress testing in asymptomatic aortic stenosis. Circulation 2017;135:1956–76. https://doi.org/10.1161/ CIRCULATIONAHA.116.025457 104. Lund O, Nielsen TT, Emmertsen K, Flø C, Rasmussen B, Jensen FT, et al. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg 1996;44:289–95. https://doi.org/10.1055/s-2007- 1012039 105. Guazzi M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2018;39:1144–61. https://doi.org/10.1093/eurheartj/ ehw180 106. Hoedemakers S, Pugliese NR, Stassen J, Vanoppen A, Claessens J, Gojevic T, et al. mPAP/CO slope and oxygen uptake add prognostic value in aortic stenosis. Circulation 2024;149:1172–82. https://doi.org/10.1161/CIRCULATIONAHA.123. 067130 107. Lancellotti P, Dulgheru R, Go YY, Sugimoto T, Marchetta S, Oury C, et al. Stress echocardiography in patients with native valvular heart disease. Heart 2018;104:807–13. https://doi.org/10.1136/heartjnl-2017-311682 108. Gentry JL III, Phelan D, Desai MY, Griffin BP. The role of stress echocardiography in valvular heart disease: a current appraisal. Cardiology 2017;137:137–50. https://doi. org/10.1159/000460274 109. Lancellotti P, Magne J. Stress echocardiography in regurgitant valve disease. Circ Cardiovasc Imaging 2013;6:840–9. https://doi.org/10.1161/CIRCIMAGING.113.000474 110. Lancellotti P, Magne J, Donal E, O’Connor K, Dulgheru R, Rosca M, et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 2012;126:851–9. https://doi.org/10.1161/ CIRCULATIONAHA.111.088427 111. Coisne A, Aghezzaf S, Galli E, Mouton S, Richardson M, Dubois D, et al. Prognostic values of exercise echocardiography and cardiopulmonary exercise testing in patients with primary mitral regurgitation. Eur Heart J Cardiovasc Imaging 2022;23:1552–61. https://doi.org/10.1093/ehjci/jeab231 112. Saeed S, Rajani R, Seifert R, Parkin D, Chambers JB. Exercise testing in patients with asymptomatic moderate or severe aortic stenosis. Heart 2018;104:1836–42. https:// doi.org/10.1136/heartjnl-2018-312939 113. Saeed S, Chambers JB. Exercise testing in aortic stenosis: safety, tolerability, clinical benefits and prognostic value. J Clin Med 2022;11:4983. https://doi.org/10.3390/ jcm11174983 114. Scarsini R, Pesarini G, Zivelonghi C, Piccoli A, Ferrero V, Lunardi M, et al. Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2018;13:1512–9. https://doi.org/10.4244/EIJ-D-17-00542 115. Pesarini G, Scarsini R, Zivelonghi C, Piccoli A, Gambaro A, Gottin L, et al. Functional assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation: influence of pressure overload on the evaluation of lesions severity. Circ Cardiovasc Interv 2016;9:e004088. https://doi.org/10.1161/circinterventions.116. 004088 116. Ahmad Y, Götberg M, Cook C, Howard JP, Malik I, Mikhail G, et al. Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity. JACC Cardiovasc Interv 2018;11:2019–31. https://doi.org/10.1016/j. jcin.2018.07.019 117. Ardehali A, Segal J, Cheitlin MD. Coronary blood flow reserve in acute aortic regurgitation. J Am Coll Cardiol 1995;25:1387–92. https://doi.org/10.1016/0735- 1097(95)00018-Y 118. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kaji S, Kawamoto T, et al. Restricted coronary flow reserve in patients with mitral regurgitation improves after mitral reconstructive surgery. J Am Coll Cardiol 1998;32:1923–30. https://doi.org/10.1016/S0735- 1097(98)00490-2 119. D’Alto M, Dimopoulos K, Coghlan JG, Kovacs G, Rosenkranz S, Naeije R. Right heart catheterization for the diagnosis of pulmonary hypertension: controversies and practical issues. Heart Fail Clin 2018;14:467–77. https://doi.org/10.1016/j.hfc.2018.03.011 120. Lindman BR, Arnold SV, Bagur R, Clarke L, Coylewright M, Evans F, et al. Priorities for patient-centered research in valvular heart disease: a report from the National Heart, Lung, and Blood Institute Working Group. J Am Heart Assoc 2020;9:e015975. https:// doi.org/10.1161/JAHA.119.015975 121. Dharmarajan K, Foster J, Coylewright M, Green P, Vavalle JP, Faheem O, et al. The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers. PLoS One 2017;12:e0175926. https:// doi.org/10.1371/journal.pone.0175926 Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026